logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/03/2026
Pfizer: The phase II clinical trial results of the new generation CDK4 inhibitor palbociclib as a second-line treatment for metastatic breast cancer are promising.
Latest
3 m ago
Nasdaq: the abbreviation of the securities is proposed to be changed to "Pentu Technology"
3 m ago
Hailian Jinhui: Intends to invest 10.4 million yuan to subscribe for 16.64% stake in industrial investment fund.
4 m ago
PTC collaborates with NVIDIA to integrate Onshape with NVIDIA's Isaac Sim, enabling the fusion of design and robot simulation.
4 m ago
San Bo Shuo: The controlling shareholder Hai Shuo Development and parties acting in concert have reduced their holdings by 2.9638%
5 m ago
State Administration of Grain and Material Reserves: To focus on the development of the "Eleventh Five-Year Plan" for grain and material reserves.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.